The clinical value of ANA positivity therefore needs to be examined since it has not only been found to be associated with higher morbidity in the obstetrical context but also with a higher rate of thrombotic relapses in comparison to ANA-negative APS patients (13–15). This evidence concerns the gene BTG3 and autoimmune polyendocrinopathy.